United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,449 | -9,969 | -23,651 | -37,288 | -75,609 |
| Depreciation Amortization | 2,276 | 2,325 | 3,135 | 3,515 | -79 |
| Accounts receivable | -3,668 | -1,378 | -5,504 | -2,969 | -398 |
| Accounts payable and accrued liabilities | 1,854 | 1,338 | -3,361 | 1,826 | 2,530 |
| Other Working Capital | 2,231 | -2,404 | -12,340 | -6,195 | 20,988 |
| Other Operating Activity | 2,636 | 1,526 | 19,463 | 2,212 | 21,453 |
| Operating Cash Flow | $20,778 | $-8,562 | $-22,258 | $-38,899 | $-31,115 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -37,474 | -44,911 | -11,218 | -152,520 | -56,659 |
| PPE Investments | -4,396 | -6,668 | -3,580 | -647 | -640 |
| Net Acquisitions | N/A | N/A | -4,914 | N/A | -10,997 |
| Purchase Of Investment | -1,000 | -2,500 | -500 | N/A | -1,000 |
| Sale Of Investment | 30,000 | 6,641 | 140,567 | 18,386 | 76,453 |
| Purchase Sale Intangibles | N/A | -300 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -300 | 0 | 0 | 0 |
| Investing Cash Flow | $-12,870 | $-47,738 | $120,355 | $-134,781 | $7,157 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -24 | -96 | -38 | -69 | -42 |
| Common Stock Issued | 7,090 | 4,085 | 245 | 6 | 210,585 |
| Common Stock Repurchased | N/A | N/A | N/A | -2,802 | -4,072 |
| Other Financing Activity | -750 | -1,982 | -22 | -17 | 142 |
| Financing Cash Flow | $6,316 | $2,007 | $185 | $-2,882 | $206,613 |
| Beginning Cash Position | 68,362 | 122,655 | 24,373 | 200,935 | 18,280 |
| End Cash Position | 82,586 | 68,362 | 122,655 | 24,373 | 200,935 |
| Net Cash Flow | $14,224 | $-54,293 | $98,282 | $-176,562 | $182,655 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,778 | -8,562 | -22,258 | -38,899 | -31,115 |
| Capital Expenditure | -5,217 | -7,004 | -3,581 | -687 | -640 |
| Free Cash Flow | 15,561 | -15,566 | -25,839 | -39,586 | -31,755 |